文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

利用人工智能评估腔面型乳腺癌中的肿瘤浸润淋巴细胞。

Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.

机构信息

Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.

Department of Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt.

出版信息

Br J Cancer. 2023 Nov;129(11):1747-1758. doi: 10.1038/s41416-023-02451-3. Epub 2023 Sep 30.


DOI:10.1038/s41416-023-02451-3
PMID:37777578
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10667537/
Abstract

BACKGROUND: Tumour infiltrating lymphocytes (TILs) are a prognostic parameter in triple-negative and human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). However, their role in luminal (oestrogen receptor positive and HER2 negative (ER + /HER2-)) BC remains unclear. In this study, we used artificial intelligence (AI) to assess the prognostic significance of TILs in a large well-characterised cohort of luminal BC. METHODS: Supervised deep learning model analysis of Haematoxylin and Eosin (H&E)-stained whole slide images (WSI) was applied to a cohort of 2231 luminal early-stage BC patients with long-term follow-up. Stromal TILs (sTILs) and intratumoural TILs (tTILs) were quantified and their spatial distribution within tumour tissue, as well as the proportion of stroma involved by sTILs were assessed. The association of TILs with clinicopathological parameters and patient outcome was determined. RESULTS: A strong positive linear correlation was observed between sTILs and tTILs. High sTILs and tTILs counts, as well as their proximity to stromal and tumour cells (co-occurrence) were associated with poor clinical outcomes and unfavourable clinicopathological parameters including high tumour grade, lymph node metastasis, large tumour size, and young age. AI-based assessment of the proportion of stroma composed of sTILs (as assessed visually in routine practice) was not predictive of patient outcome. tTILs was an independent predictor of worse patient outcome in multivariate Cox Regression analysis. CONCLUSION: AI-based detection of TILs counts, and their spatial distribution provides prognostic value in luminal early-stage BC patients. The utilisation of AI algorithms could provide a comprehensive assessment of TILs as a morphological variable in WSIs beyond eyeballing assessment.

摘要

背景:肿瘤浸润淋巴细胞(TILs)是三阴性和人表皮生长因子受体 2(HER2)阳性乳腺癌(BC)的预后参数。然而,它们在管腔(雌激素受体阳性和 HER2 阴性(ER+/HER2-))BC 中的作用仍不清楚。在这项研究中,我们使用人工智能(AI)来评估 TILs 在大型特征明确的管腔 BC 队列中的预后意义。

方法:对 2231 例具有长期随访的管腔早期 BC 患者的苏木精和伊红(H&E)染色全切片图像(WSI)进行有监督的深度学习模型分析。量化了基质 TILs(sTILs)和肿瘤内 TILs(tTILs),并评估了它们在肿瘤组织内的空间分布以及 sTILs 所涉及的基质比例。确定了 TILs 与临床病理参数和患者结局的关系。

结果:观察到 sTILs 和 tTILs 之间存在很强的正线性相关性。高 sTILs 和 tTILs 计数,以及它们与基质和肿瘤细胞的接近程度(共发生)与不良的临床结局和不利的临床病理参数相关,包括高肿瘤分级、淋巴结转移、大肿瘤大小和年轻年龄。基于 AI 的评估(在常规实践中通过肉眼评估)sTILs 组成的基质比例与患者结局无预测价值。在多变量 Cox 回归分析中,tTILs 是患者预后不良的独立预测因子。

结论:基于 AI 的 TILs 计数及其空间分布的检测为管腔早期 BC 患者提供了预后价值。AI 算法的应用可以提供对 TILs 作为 WSI 中形态学变量的全面评估,超越肉眼评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c130/10667537/90595cf8b117/41416_2023_2451_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c130/10667537/c0776a957e91/41416_2023_2451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c130/10667537/c57cb095a1db/41416_2023_2451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c130/10667537/90595cf8b117/41416_2023_2451_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c130/10667537/c0776a957e91/41416_2023_2451_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c130/10667537/c57cb095a1db/41416_2023_2451_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c130/10667537/90595cf8b117/41416_2023_2451_Fig3_HTML.jpg

相似文献

[1]
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.

Br J Cancer. 2023-11

[2]
Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.

Histopathology. 2018-10-9

[3]
Artificial intelligence-based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease-specific survival in triple-negative breast cancer.

J Pathol. 2023-5

[4]
Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer.

Eur J Cancer. 2019-7-11

[5]
Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers.

Oncotarget. 2016-7-12

[6]
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.

Lancet Oncol. 2017-12-7

[7]
Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.

Target Oncol. 2018-12

[8]
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.

Eur J Cancer. 2020-1-16

[9]
Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.

Breast Cancer Res Treat. 2023-6

[10]
Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.

Breast Cancer Res Treat. 2016-7

引用本文的文献

[1]
Artificial Intelligence-Based Pathology to Assist Prediction of Neoadjuvant Therapy Responses for Breast Cancer.

Cancer Med. 2025-8

[2]
Differentiation of breast cancer subtypes and correlation with biological status using functional magnetic resonance imaging: comparison with amide proton transfer-weighted imaging and diffusion-weighted imaging.

Quant Imaging Med Surg. 2025-7-1

[3]
Tumor-Infiltrating Lymphocytes in Breast and Female Genital Tract Cancers: Overlooked Potential and Unexplored Frontiers.

Cancer Med. 2025-7

[4]
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma.

JAMA Netw Open. 2025-7-1

[5]
Advanced Deep Learning Approaches in Detection Technologies for Comprehensive Breast Cancer Assessment Based on WSIs: A Systematic Literature Review.

Diagnostics (Basel). 2025-4-30

[6]
Toward Optimizing the Impact of Digital Pathology and Augmented Intelligence on Issues of Diagnosis, Grading, Staging, and Classification.

Mod Pathol. 2025-7

[7]
Computational pathology for breast cancer: Where do we stand for prognostic applications?

Breast. 2025-6

[8]
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.

NPJ Breast Cancer. 2025-3-7

[9]
Research trends on AI in breast cancer diagnosis, and treatment over two decades.

Discov Oncol. 2024-12-18

[10]
Thematic trends and knowledge-map of tumor-infiltrating lymphocytes in breast cancer: a scientometric analysis.

Front Oncol. 2024-11-1

本文引用的文献

[1]
Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring.

Front Immunol. 2022

[2]
Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations.

J Pathol Clin Res. 2022-3

[3]
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.

NPJ Breast Cancer. 2021-12-1

[4]
Biomarkers for breast cancer immunotherapy: PD-L1, TILs, and beyond.

Expert Opin Investig Drugs. 2022-6

[5]
Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.

Mol Clin Oncol. 2021-12

[6]
A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer.

EBioMedicine. 2021-8

[7]
Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis.

Breast. 2021-10

[8]
The Immunology of Hormone Receptor Positive Breast Cancer.

Front Immunol. 2021

[9]
Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer.

BMC Womens Health. 2021-5-29

[10]
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer.

Cancer Metastasis Rev. 2021-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索